Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ru Zhou

Showing results (311-320 of 334) with videos related to

Pageof 34
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|December 6, 2005
S-adenosyl-L-homocysteine hydrolase inactivation curtails ovalbumin-induced immune responsesYun-Feng Fu, Jun-Xia Wang, Yang Zhao, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 6, 2005
Periplocoside E, an effective compound from Periploca sepium Bge, inhibited T cell activation in vitro and in vivoYi-Na Zhu, Wei-Min Zhao, Yi-Fu Yang, et al.
Acta Pharmacologica Sinica|August 3, 2021
Histone deacetylase inhibitor givinostat attenuates nonalcoholic steatohepatitis and liver fibrosisHe-Ming Huang, Shi-Jie Fan, Xiao-Ru Zhou, et al.
Pharmaceutical Biology|March 8, 2014
Neuroprotective effects of oxysophocarpine on neonatal rat primary cultured hippocampal neurons injured by oxygen-glucose deprivation and reperfusionQing-Luan Zhu, Yu-Xiang Li, Ru Zhou, et al.
Journal of Natural Medicines|July 6, 2015
Protective effects of aloperine on neonatal rat primary cultured hippocampal neurons injured by oxygen-glucose deprivation and reperfusionNing-Tian Ma, Ru Zhou, Ren-Yuan Chang, et al.
IBRO Neuroscience Reports|December 5, 2024
Causes and countermeasures for the increased infection and COVID-19 mortality rates in patients with schizophreniaZhen-Ying Li, Yu-Qian Li, Jing-Ru Zhou, et al.
Bioorganic & Medicinal Chemistry Letters|February 23, 2002
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. Part 7: structure-activity studies of bicyclic 2-pyridone-containing peptidomimeticsPeter S Dragovich, Thomas J Prins, Ru Zhou, et al.
Bioorganic & Medicinal Chemistry Letters|May 14, 2009
Pyridones as glucokinase activators: identification of a unique metabolic liability of the 4-sulfonyl-2-pyridone heterocycleJeffrey A Pfefferkorn, Jihong Lou, Martha L Minich, et al.
American Journal of Cancer Research|April 9, 2024
ODF3B affects the proliferation and apoptosis of glioma via the JAK/STAT pathwayXing-Zhao Luan, Su-Xin Yuan, Xiao-Jing Chen, et al.
Journal of Biochemistry|January 8, 2025
Identification of a novel Eps 15 homology domain-containing protein 1 (EHD1) and EHD4-binding motif in phostensinKuang-Yung Huang, Hui-Chun Yu, Ming-Chi Lu, et al.
Pageof 34

Showing results (311-320 of 334) with videos related to

Sort By:
Pageof 34
The Journal of Pharmacology and Experimental Therapeutics|December 6, 2005
S-adenosyl-L-homocysteine hydrolase inactivation curtails ovalbumin-induced immune responsesYun-Feng Fu, Jun-Xia Wang, Yang Zhao, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 6, 2005
Periplocoside E, an effective compound from Periploca sepium Bge, inhibited T cell activation in vitro and in vivoYi-Na Zhu, Wei-Min Zhao, Yi-Fu Yang, et al.
Acta Pharmacologica Sinica|August 3, 2021
Histone deacetylase inhibitor givinostat attenuates nonalcoholic steatohepatitis and liver fibrosisHe-Ming Huang, Shi-Jie Fan, Xiao-Ru Zhou, et al.
Pharmaceutical Biology|March 8, 2014
Neuroprotective effects of oxysophocarpine on neonatal rat primary cultured hippocampal neurons injured by oxygen-glucose deprivation and reperfusionQing-Luan Zhu, Yu-Xiang Li, Ru Zhou, et al.
Journal of Natural Medicines|July 6, 2015
Protective effects of aloperine on neonatal rat primary cultured hippocampal neurons injured by oxygen-glucose deprivation and reperfusionNing-Tian Ma, Ru Zhou, Ren-Yuan Chang, et al.
IBRO Neuroscience Reports|December 5, 2024
Causes and countermeasures for the increased infection and COVID-19 mortality rates in patients with schizophreniaZhen-Ying Li, Yu-Qian Li, Jing-Ru Zhou, et al.
Bioorganic & Medicinal Chemistry Letters|February 23, 2002
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. Part 7: structure-activity studies of bicyclic 2-pyridone-containing peptidomimeticsPeter S Dragovich, Thomas J Prins, Ru Zhou, et al.
Bioorganic & Medicinal Chemistry Letters|May 14, 2009
Pyridones as glucokinase activators: identification of a unique metabolic liability of the 4-sulfonyl-2-pyridone heterocycleJeffrey A Pfefferkorn, Jihong Lou, Martha L Minich, et al.
American Journal of Cancer Research|April 9, 2024
ODF3B affects the proliferation and apoptosis of glioma via the JAK/STAT pathwayXing-Zhao Luan, Su-Xin Yuan, Xiao-Jing Chen, et al.
Journal of Biochemistry|January 8, 2025
Identification of a novel Eps 15 homology domain-containing protein 1 (EHD1) and EHD4-binding motif in phostensinKuang-Yung Huang, Hui-Chun Yu, Ming-Chi Lu, et al.
Pageof 34